Masoud Maher 4
4 · MAXCYTE, INC. · Filed Mar 29, 2022
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Masoud Maher
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-25+242,000→ 242,000 totalExercise: $7.12Exp: 2032-03-24→ Common Stock (242,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date.